PacWest Financial Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
SGA
PacWest Financial Management's NVO Position: Q4 2016 in Review
PacWest Financial Management increased its Novo Nordisk (NVO) stake by 2.7% in Q4 2016, buying an estimated $44.1K and bringing the position to 91,810 shares worth $16.5M. The position accounts for 0.97% of the portfolio, ranked #43.
PacWest Financial Management first reported a position in NVO in Q2 2013 and has held it in 15 quarters since. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.
- PacWest Financial Management held 91,810 shares of Novo Nordisk worth $16.5M as of Q4 2016.
- PacWest Financial Management bought 2,430 Novo Nordisk shares in Q4 2016, an estimated $44.1K.
- Novo Nordisk made up 0.97% of PacWest Financial Management's portfolio in Q4 2016, its #43 holding.
- PacWest Financial Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 15 quarters since.
- 483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.
Based on PacWest Financial Management's 13F filing for Q4 2016, filed 10 Jan 2017.